Search Results - "van Doorn, Martijn B A"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects by Doorn, Martijn BA van, Santo, Sonia M. Espirito, Meijer, Piet, Kamerling, Ingrid M, Schoemaker, Rik C, Dirsch, Verena, Vollmar, Angelika, Haffner, Thomas, Gebhardt, Rolf, Cohen, Adam F, Princen, Hans M, Burggraaf, Jacobus

    Published in The American journal of clinical nutrition (01-12-2006)
    “…BACKGROUND: Epidemiologic studies suggest that garlic may have beneficial effects on risk factors associated with cardiovascular disease (CVD). However, these…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Complement Activation in Inflammatory Skin Diseases by Giang, Jenny, Seelen, Marc A J, van Doorn, Martijn B A, Rissmann, Robert, Prens, Errol P, Damman, Jeffrey

    Published in Frontiers in immunology (16-04-2018)
    “…The complement system is a fundamental part of the innate immune system, playing a crucial role in host defense against various pathogens, such as bacteria,…”
    Get full text
    Journal Article
  7. 7

    Needle‐free jet injection‐induced small‐droplet aerosol formation during intralesional bleomycin therapy by Bik, Liora, Wolkerstorfer, Albert, Bekkers, Vazula, Prens, Errol P., Haedersdal, Merete, Bonn, Daniel, Doorn, Martijn B. A.

    Published in Lasers in surgery and medicine (01-04-2022)
    “…Objectives Needle‐free jet injectors are frequently used in dermatological practice. Injection‐generated small‐droplet aerosols could be harmful upon…”
    Get full text
    Journal Article
  8. 8

    Needle-free electronically controlled jet injection with corticosteroids in recalcitrant keloid scars: a retrospective study and patient survey by Bik, Liora, Elmzoon, Ixora, Wolkerstorfer, Albert, Prens, Errol P., van Doorn, Martijn B. A.

    Published in Lasers in medical science (02-11-2023)
    “…First-line treatment of keloids consists of intralesional needle injections with corticosteroids, but generally entails multiple painful sessions, resulting in…”
    Get full text
    Journal Article
  9. 9

    Clinical endpoints of needle‐free jet injector treatment: An in depth understanding of immediate skin responses by Bik, Liora, Doorn, Martijn B. A., Boeijink, Neill, Wennekers, Medelyn, Meesters, Arne A., Bloemen, Peter, Haedersdal, Merete, Wolkerstorfer, Albert

    Published in Lasers in surgery and medicine (01-07-2022)
    “…Objectives Needle‐free jet injectors have been used in dermatological practice for many years. However, predefined clinical endpoints that guide physicians to…”
    Get full text
    Journal Article
  10. 10

    Electronic Pneumatic Injection‐Assisted Dermal Drug Delivery Visualized by Ex Vivo Confocal Microscopy by Bik, Liora, Doorn, Martijn B. A., Biskup, Edyta, Ortner, Vinzent K., Haedersdal, Merete, Olesen, Uffe H.

    Published in Lasers in surgery and medicine (01-01-2021)
    “…Background and Objectives Electronic pneumatic injection (EPI) is a technique for dermal drug delivery, which is increasingly being used in clinical practice…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review by Edwards, Gareth, Diercks, Gilles F H, Seelen, Marc A J, Horvath, Barbara, van Doorn, Martijn B A, Damman, Jeffrey

    Published in Frontiers in immunology (26-06-2019)
    “…Autoimmune bullous dermatoses (AIBD) are characterized by circulating autoantibodies that are either directed against epidermal antigens or deposited as immune…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Successful pharmacological intervention at different levels of the complement system in an in vitro complement fixation model for bullous pemphigoid by Giang, Jenny, Doorn, Martijn B. A., Diercks, Gilles F. H., Cordoba, Santiago Rodriguez, Bosch, Thierry P. P., Schreurs, Marco W. J., Poppelaars, Felix, Damman, Jeffrey

    Published in Experimental dermatology (01-05-2023)
    “…Bullous pemphigoid (BP) is characterized by deposition of immunoglobulins and complement along the epidermal basement membrane (BM). In humans, there is a lack…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations by van Bezooijen, Ji S, Koch, Birgit C P, van Doorn, Martijn B A, Prens, Errol P, van Gelder, Teun, Schreurs, Marco W J

    Published in Therapeutic drug monitoring (01-08-2016)
    “…To optimize treatment of inflammatory diseases, interest in the measurement of anti-tumor necrosis factor alpha (anti-TNFα) serum drug concentrations is…”
    Get full text
    Journal Article
  20. 20

    Effectiveness and tolerability of personalized omalizumab treatment in patients with chronic inducible urticaria by Buters, Thomas P., van der Velden, Willemijn A.C., Abdisalaam, Ismahaan, van Maaren, Maurits S., van Doorn, Martijn B.A.

    “…[...]published evidence of omalizumab in CIndU is limited to small case series and randomized controlled trials evaluating the standard dosing regimen (300…”
    Get full text
    Journal Article